Sanofi shares are listed on the Euronext Paris and are also available on the New York Stock Exchange (NYSE) in the form of American Depositary Shares (ADS) under the symbol SNY.
JPMorgan Chase Bank acts as a depositary of our ADSs and issues American Depositary Receipts (ADRs) for these shares entitling the shareholder to all dividends and capital gains.
A dedicated team is available in the U.S. to answer the questions of U.S. investors and individual shareholders.
- If you are a U.S. individual shareholder please contact:
Phone - toll free in the U.S.: (1) 888 516 3002
Email for individual shareholders
- Institutional investors should contact:
Phone: United States: (1) 908 981 5560
Email for institutional investors
- JPMorgan Chase Bank, N.A. – Sanofi shareholder services
Toll-free number in the U.S.: (1) 877 272 9475
For international callers: (1) 651 453 2128
How to purchase ADRs
To purchase Sanofi ADRs, shareholders may contact a licensed stockbroker or may buy directly from our ADR depository bank, JPMorgan Chase, through a Direct Purchase Plan. The Plan provides first-time purchasers and existing shareholders of Sanofi ADSs with a convenient and economical way to invest in Sanofi. Participants can enjoy the same benefits as an investor who holds physical certificates; they remain the registered owner of the shares and have full control over their investment decisions.
Income Tax Information
ADR dividends are paid in U.S. dollars and are generally taxable, just like dividends on U.S. shares. In addition, the Republic of France, Sanofi’s home country, may withhold taxes. Depending on individual circumstances, foreign taxes withheld might be applied as a credit against U.S. taxes, or tax reclaim opportunities may be offered. For specific information, consult your tax adviser.
You may also call the J.P. Morgan Global Tax line at: (1) 800 929 5484
To obtain further tax information, please read our current annual report on Form 20-F filed with the Securities and Exchange Commission.
Final information for 2017 dividends
The Annual General Meeting 2018 approved a dividend of €3.03 per ordinary share for 2017 results
Record date for ADRs: May 10, 2018
Payment/value date for ADRs: June 4, 2018
|Dividend per ordinary share||€3.03|
|Ratio ADR:ordinary share||1:2|
|Dividend per ADR||€1.515|
|Foreign exchange date||05/15/2018|
|Final foreign exchange rate*
Inclusive of a fee of 0.002300
|Withholding tax rate||15%||30%||0%|
|Rate per DR||1.790623||1.790623||1.790623|
|Final dividend rate per DR||$1.464030||$1.203437||$1.732623|
*Funds provided to J. P. Morgan in a foreign currency may have been converted to U.S. dollars through a foreign exchange transaction with J. P. Morgan or an affiliate. The foreign exchange rate applied to the foreign currency is determined by J.P. Morgan in its sole discretion and is either (1) the WMR Rate or (2) the JP Morgan Rate plus, in either case, up to 20 basis points.
J.P. Morgan collects fees ("Fees") from holders of depositary receipts. These Fees are described in the deposit agreement and may include, without limitation, Fees for (i) the issuance and cancellation of depositary receipts, (ii) services performed in administering the depositary receipts and (iii) distributions of cash. In most cases, J.P. Morgan reimburses the issuer for certain expenses related to the depositary receipts program and incurred by the issuer in connection with such program or shares revenue with the issuer received by J.P. Morgan from such Fees or revenues generated in connection with the Program.
History of Sanofi annual dividends per ADR
|Amount||Record date||Payment/Value date|
|2016||$1.64||May 15, 2017||June 7, 2017|
|2015||$1.66||May 9, 2016||June 1, 2016|
|2014||$1.61||May 8, 2015||June 2, 2015|
|2013||$1.91||May 9, 2014||June 5, 2014|
|2012||$1.86||May 8, 2013||June 5, 2013|
|2011||$1.75||May 9, 2012||May 30, 2012|
|2010||$1.82||May 13, 2011||June 24, 2011|
|2009||$1.47||May 19, 2010||June 14, 2010|
|2008||$1.44||April 22, 2009||May 29, 2009|
|2007||$1.51||May 20, 2008||June 13, 2008|